Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Lung Neoplasms × olaparib × Clear all

Phase

Status

Sponsor Class

OTHER 4 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thymoma 1 Sarcoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Mesothelioma 1 Lung Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 5 Cisplatin 5 Drug Therapy 3 Docetaxel 3 Radiotherapy 2 Pemetrexed 2 Paclitaxel 2 Oxaliplatin 2 Gefitinib 2 Erlotinib Hydrochloride 2 olaparib 1 Watchful Waiting 1 Thoracoscopy 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Risk Factors 1 Radiation 1 Olanzapine 1 Neoadjuvant Therapy 1 Muscle Stretching Exercises 1 Irinotecan 1 Indocyanine Green 1 Fish Oils 1 Environmental Biomarkers 1 Enteral Nutrition 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Dietary Supplements 1 Dexamethasone 1 Continuous Positive Airway Pressure 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01788332 2018-10-26

PIN

Velindre NHS Trust

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡